Vaccines

Smallpox Vaccine

This research study will evaluate the safety and effectiveness of a vaccine to protect against Smallpox. This study will last approximately up to 39 weeks with 6 number of visits to our office and 1 telephone call. While the World Health Organization officially declared successful global eradication in 1980, the threat of a small pox outbreak still exists through bioterrorism and risk of natural re-emergence of the virus.

*Compensation for time and travel may be available to those who qualify.

Pneumococcal Vaccine

This study is to evalute the safety and effectiveness of a study vaccine that may provide broader coverage against the leading serotypes associated with pneumococcal disease. The study will last approximately 6 months with two visits to our office and two telephone calls.

*Compensation for time and travel may be available to those who qualify.

E. Coli Vaccine

RCR is currently enrolling healthy 60-85 year olds to evaluate a vaccine that could potentially prevent E. Coli that can cause sepsis.

Pediatrics Meningitis Vaccine

Two month old patients of Legacy Pediatrics may have an opportunity to participate in this study.

C. Diff. Vaccine

Investigational vaccine to prevent Clostridium Difficile

*Compensation for time and travel may be available to those who qualify.